Listed

Central Garden & Pet Co: Form 10-Q for the period ended Mar 28, 2020

Filed with the SEC on May 7, 2020 and accepted by EDGAR at May 7, 2020, 14:59 ET.

Share

Management's discussion and analysis

As filed, 59,511 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our Company

Central Garden & Pet Company (“Central”) is a leading innovator, producer and distributor of branded and private label products for the lawn & garden and pet supplies markets in the United States. The total annual retail sales of the pet food, treats & chews, supplies and live animal industry in 2018 was estimated by Packaged Facts and the pet industry to have been approximately $51.9 billion. We estimate the annual retail sales of the pet supplies, live animal, and treats & chews and natural pet food markets in the categories in which we participate to be approximately $27.4 billion. The total lawn and garden consumables, decorative products, live plant and outdoor cushions and pillows industry in the United States is estimated by Packaged Facts, The Freedonia Group and TechNavio to have been approximately $23.3 billion in annual retail sales in 2018, including fertilizer, pesticides, growing media, seeds, mulch, other consumables, decorative products, live plants and outdoor cushions and pillows. We estimate the annual retail sales of the lawn and garden consumables, decorative products and live plant markets in the categories in which we participate to be approximately $16.3 billion.

Our pet supplies products include products for dogs and cats, including edible bones, premium healthy edible and non-edible chews, natural dog and cat food and treats, toys, pet carriers, grooming supplies and other accessories; products for birds, small animals and specialty pets, including food, cages and habitats, toys, chews and related accessories; animal and household health and insect control products; live fish and products for fish, reptiles and other aquarium-based pets, including aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food and supplements, and information and knowledge resources; and products for horses and livestock. These products are sold under the brands including Adams™, Aqueon®, Avoderm®, C&S Products®, Cadet®, Farnam®, Four Paws®, Kaytee®, K&H Pet Products®, Nylabone®, Pinnacle®, TFH™, Zilla® as well as a number of other brands including Altosid®, Comfort Zone®, Coralife®, Interpet®, Pet Select® and Zodiac®.

Our lawn and garden supplies products include proprietary and non-proprietary grass seed; wild bird feed, bird feeders, bird houses and other birding accessories; weed, grass, and other herbicides, insecticide and pesticide products; fertilizers; and decorative outdoor lifestyle products including pottery, as well as live plants and outdoor cushions and pillows. These products are sold under the brands AMDRO®, Arden Companies™, Ironite®, Pennington®, and Sevin®, as well as a number of other brand names including Lilly Miller®, Over-N-Out®, Smart Seed® and The Rebels®.

In fiscal 2019, our consolidated net sales were $2,383 million, of which our Pet segment, or Pet, accounted for approximately $1,385 million and our Garden segment, or Garden, accounted for approximately $998 million. In fiscal 2019, our operating income was $152 million consisting of income from our Pet segment of $123 million, income from our Garden segment of $102 million and corporate expenses of $73 million.

We were incorporated in Delaware in May 1992 as the successor to a California corporation that was formed in 1955. Our executive offices are located at 1340 Treat Boulevard, Suite 600, Walnut Creek, California 94597, and our telephone number is (925) 948-4000. Our website is www.central.com (http://www.central.com). The information on our website is not incorporated by reference in this annual report.

Recent Developments

Fiscal 2020 Second Quarter Financial Performance:

  • Net sales increased $29.5 million, or 4.4%, from the prior year quarter to $703.2 million due primarily to the inclusion of two acquisitions that were not part of the second quarter fiscal 2019 results. Pet segment sales increased $22.6 million, and Garden segment sales increased $6.9 million.
  • Organic net sales increased 0.5%. Our Pet segment organic net sales increased 3.8% and our Garden segment's declined 2.8%.
  • Gross profit increased $1.1 million, and gross margin declined 110 basis points to 29.5%.
  • Selling, general & administrative expense declined $2.9 million to $141.0 million and decreased as a percentage of net sales 130 basis points to 20.1%.
  • Operating income increased $3.9 million from the prior year quarter, to $66.1 million in the second quarter of fiscal 2020.
  • Net income in the second quarter of fiscal 2020 was $42.7 million, or $0.78 per diluted share, compared to net income of $42.4 million, or $0.73 per diluted share, in the second quarter of fiscal 2019.

DMC Business Unit

In November 2019, our DMC business unit in our Pet Segment experienced a fire in one of its leased properties located in Athens, Texas, which resulted in inventory, property-related and business interruption losses in the estimated range of $35 - $40 million. We had approximately $6 million of cost in excess of insurance proceeds recorded on our balance sheet at quarter end. We currently believe our insurance coverage is sufficient to cover the asset losses as well as the business interruption loss associated with this event.

In April 2020, our DMC business unit in our Pet segment experienced a second fire in one of its leased properties located in Athens, Texas. As a result, we sustained inventory and property-related losses estimated to be approximately $10 million. This event has temporarily had a limited impact on our ability to fulfill orders to certain of our customers. We currently believe our insurance coverage is sufficient to cover the asset losses as well as the business interruption loss associated with this event.

COVID-19 Impact

Over the last few months, we have seen the effects a novel strain of coronavirus (“COVID-19”) is having globally on human health, the economy and society at large. The impact of COVID-19 and measures to prevent its spread are affecting our business in a number of ways. Central is considered an essential business in most jurisdictions and almost all of our employees continue to work to meet essential needs. We have been actively addressing the COVID-19 situation and its impact on our employees and business.

From the beginning, our priority has been the safety of our employees, customers and consumers. We are proud of all that our employees have done to prioritize the health and safety of fellow team members while collaborating across the business to ensure we operate as safely and seamlessly as possible in order to provide a steady supply of product to our customers. To that end, we mobilized a cross-functional task force focused on understanding and communicating the critical issues related to the COVID-19 pandemic to mitigate the potential impacts to our people and business.

Our teams have worked hard to do the following:

  • Ensure constant communication and regularly share pertinent information around health, safety and benefits;
  • Take extra precautions in our manufacturing facilities, distribution centers and offices with guidance from health authorities including social distancing, staggering shifts, procuring necessary personal protection equipment, partitions, sanitation supplies and investing in regular deep cleanings of our facilities;
  • Implemented travel restrictions and work-from-home policies for employees who have the ability to work from home in accordance with shelter-in-place orders; and
  • Adhere to all local, state and federal requirements.

Central is seeing varying impacts to our Garden and Pet businesses due to COVID-19. In March, we experienced increased demand in pet consumables due to consumers stocking up on products as the COVID-19 shelter-in-place mandates were implemented. We also saw reduced consumption on other items, such as live fish and live plants, due to in-store curtailments of foot traffic and limited access to outdoor garden departments. The garden business is seasonal and the timing of the COVID-19 outbreak is occurring during the garden season. Additionally, we saw a pronounced shift to the e-commerce channel and a slow-down in brick and mortar retailers.

Our facilities have largely been exempt or partially exempt from government closure orders. We have experienced temporary closures of certain facilities, though there has not been a material impact from a plant closure to date. At some of our facilities, we have experienced reduced productivity and increased employee absences, which we expect to continue during the current pandemic. The pandemic and near-term increase in demand has created operational challenges for our distribution network, though none have had a material impact on our results to date. In our supply chain, it is possible we will experience increased operational and logistics costs, though these did not have a material impact on our second fiscal quarter results. We may experience additional disruptions in our supply chain as the pandemic continues, though we cannot reasonably estimate the potential impact or timing of those events, and we may not be able to mitigate such impact.

We believe we are financially strong and expect to be able to maintain adequate liquidity as we manage through the current economic and health environment. As of March 28, 2020, we had approximately $330 million in cash. We also have a revolving credit facility that provides up to a $400 million principal amount with an additional $200 million available with the consent of the lenders. As of March 28, 2020, there were no borrowings outstanding under the Credit Facility. Subsequent to quarter end, we borrowed $200 million under our revolving credit facility to increase financial flexibility while we navigate an uncertain COVID-19 economic environment.

We anticipate many small customers may permanently close, and we may experience collection delinquencies as customers seek to preserve liquidity. Additionally, we have small company equity method investees, intangible assets and other long-lived assets whose value is dependent on cashflows. These investments and other assets could be impacted by the COVID-19 pandemic and, therefore, may be more susceptible to impairment. Management's assessment of possible asset impairment involves numerous assumptions that involve significant judgment. As a result of the uncertainties associated with the COVID-19 pandemic, the shelter-in-place orders and the post-COVID-19 economic recovery, these factors will be even more difficult to estimate. Although no impairment charges were indicated or recorded in our second fiscal quarter, we may be required to write-off certain assets that could be material in future periods.

As a result of the COVID-19 pandemic and its current impact on society and the global economic environment, our work on developing our Vision 2025 strategy has been slowed, and we now expect to communicate that strategy in late 2020.

While the unfavorable impact of COVID-19 began to adversely affect the performance in certain portions of our portfolio in March, we expect that most of the impact on our financial results will be in our third and fourth fiscal quarters. As a result of the COVID-19 customer and consumer impact, a few of our businesses experienced demand head winds in March which continued into April, and it is difficult to predict when more normal order patterns may return. These businesses include our live animal, live plant, pet bedding and aquatics businesses and our UK operations. In the current uncertain environment, our employees, customers and consumers will be our priority as we manage our business to deliver long-term growth.

Results of Operations

Three Months Ended March 28, 2020

Compared with Three Months Ended March 30, 2019

Net Sales

Net sales for the three months ended March 28, 2020 increased $29.5 million, or 4.4%, to $703.2 million from $673.7 million for the three months ended March 30, 2019. Organic net sales, which excludes the impact of acquisitions and divestitures in the last 12 months, increased $3.4 million, or 0.5%, as compared to the fiscal 2019 quarter. Our branded product sales increased $9.7 million, and sales of other manufacturers’ products increased $19.8 million.

Pet net sales increased $22.6 million, or 6.7%, to $360.8 million for the three months ended March 28, 2020 from $338.2 million for the three months ended March 30, 2019. The increase in net sales was due to a $12.7 million, or 3.8%, increase in organic net sales and $9.9 million of sales from C&S Products, which we acquired in May 2019. The increase in organic net sales was due primarily to a volume-based sales increase in our dog and cat business and in third-party sales. Both businesses were aided by COVID-19 related consumable pantry loading, and, for our dog and cat business, the increased sales occurred despite headwinds from a fire in one of our pet bedding facilities in the first quarter of fiscal 2020. These increases were partially offset by lower sales in our live fish business due to a major retailer's decision in 2019 to exit the live fish business, and the COVID-19 negative impact on the access to live fish at retailers. Pet branded product sales increased $15.6 million, and sales of other manufacturers' products increased $7.0 million.

Garden net sales increased $6.9 million, or 2.1%, to $342.4 million for the three months ended March 28, 2020 from $335.5 million for the three months ended March 30, 2019. The increase in net sales was due primarily to sales from Arden, which became 100% owned due to our acquisition of the remaining equity interest in February 2019, partially offset by lower organic sales, which decreased $9.3 million, or 2.8%. The decrease in Garden organic sales was due to lower grass seed sales, impacted by the loss of customer promotion support due to COVID-19, lost distribution and lower in-store traffic due to COVID-19, and our exit of the fashion decor pottery product line in mid-2019. These decreases were partially offset by increased sales of third-party products. Garden branded sales decreased $5.9 million, and sales of other manufacturers' products increased $12.8 million.

Gross Profit

Gross profit for the three months ended March 28, 2020 increased $1.1 million, or 0.5%, to $207.1 million from $206.1 million for the three months ended March 30, 2019. Gross margin declined 110 basis points to 29.5% for the three months ended March 28, 2020 from 30.6% for the three months ended March 30, 2019. The gross profit increase was due to the Pet segment while both segments contributed to the gross margin decline.

In the Pet segment, gross profit increased but gross margin declined. The gross profit increase was due primarily to recently acquired C&S Products. The gross margin decline was due primarily to lower sales in our live fish business, impacted by a major retailer’s decision in 2019 to exit the live fish business and the impact of COVID-19 on deemed non-essential retail products, and the negative impact on product mix of increased sales of third-party products.

In the Garden segment, both gross profit and gross margin declined. Both gross profit and gross margin were negatively impacted by an unfavorable sales mix due primarily to reduced sales and a lower gross margin in our grass seed business and our exit from the fashion décor pottery product line. Additionally, gross margin was negatively impacted by increased third-party sales.

Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased $2.9 million, or 2.0%, to $141.0 million for the three months ended March 28, 2020 from $143.9 million for the three months ended March 30, 2019. Selling, general and administrative expense decreased in both operating segments partially offset by an increase in corporate expense. As a percentage of net sales, selling, general and administrative expenses decreased to 20.1% for the three months ended March 28, 2020, compared to 21.4% in the comparable prior year quarter.

Selling and delivery expense was relatively flat at $71.8 million for the three months ended March 28, 2020 as compared to the prior year quarter. Increased costs from our two recent acquisitions were offset by cost saving initiatives enacted in response to a retailer’s exit from the live fish business and our exit from the fashion décor pottery product line in 2019.

Warehouse and administrative expense decreased $2.8 million, or 3.9%, to $69.2 million for the three months ended March 28, 2020 from $72.0 million for the three months ended March 30, 2019. In our operating segments, cost reductions in response to a retailer’s exit from the live fish business, our exit from the fashion décor pottery product line in 2019 and an insurance settlement more than offset costs from our two recent acquisitions. Corporate expenses increased $2.3 million due primarily to increased medical insurance and equity compensation costs. Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resources, and information technology functions.

Operating Income

Operating income increased $3.9 million to $66.1 million for the three months ended March 28, 2020 from $62.2 million for the three months ended March 30, 2019. The increase in operating income was attributable to increased sales and lower selling, general and administrative costs partially offset by a lower gross margin. Our operating margin increased from 9.2% in the prior year quarter to 9.4% in the current year quarter due to an increase in sales and a 130 basis point decline in selling, general and administrative expense as a percentage of net sales partially offset by a 110 basis point decline in gross margin.

Pet operating income increased $6.6 million, or 24.6%, to $33.6 million for the three months ended March 28, 2020 from $27.0 million for the three months ended March 30, 2019. Pet operating income increased due to increased sales, due to an acquisition and increased organic sales, increased gross profit and decreased selling, general and administrative costs. Pet operating margin increased 130 basis points due to increased sales and lower selling, general and administrative expense as a percentage of net sales partially offset by a lower gross margin.

Garden operating income decreased $0.4 million, or 0.6%, to $53.0 million for the three months ended March 28, 2020 from $53.4 million for the three months ended March 30, 2019. Garden operating income decreased due to lower gross profit and increased selling, general and administrative expense that more than offset increased sales. Garden operating margin declined 40 basis points due to a lower gross margin partially offset by lower selling, general and administrative expense as a percentage of sales.

Corporate operating expense increased $2.3 million, or 12.9%, to $20.5 million for the three months ended March 28, 2020 from $18.2 million for the three months ended March 30, 2019. Corporate expense increased due to increased medical insurance and non-cash equity compensation expense.

Net Interest Expense

Net interest expense for the three months ended March 28, 2020 increased $0.9 million, or 11.3%, to $9.3 million from $8.4 million for the three months ended March 30, 2019. The increase in net interest expense was due to lower interest income from earnings on cash due to the lower rates available on our cash balance during the quarter.

Debt outstanding on March 28, 2020 was $693.7 million compared to $697.8 million at March 30, 2019.

Other Income (Expense)

Other income (expense) is comprised of income or losses from investments accounted for under the equity method of accounting and foreign currency exchange gains and losses. Other expense was $1.0 million for the quarter ended March 28, 2020 compared to income of $0.5 million for the quarter ended March 30, 2019. The change was due primarily to foreign exchange losses in the quarter and the absence of income from our formerly held equity interest in Arden. The Arden business has been part of our consolidated results since our purchase of the remaining ownership interest in February 2019.

Income Taxes

Our effective income tax rate was 22.7% for the quarter ended March 28, 2020 compared to 21.3% for the quarter ended March 30, 2019. The higher effective income tax rate in the current year quarter was due primarily to a lower stock compensation benefit in the current year quarter compared to the prior year quarter.

Net Income and Earnings Per Share

Our net income in the second quarter of fiscal 2020 was $42.7 million, or $0.78 per diluted share, compared to net income of $42.4 million, or $0.73 per diluted share, in the second quarter of fiscal 2019.

Six Months Ended March 28, 2020

Compared with Six Months Ended March 30, 2019

Net Sales

Net sales for the six months ended March 28, 2020 increased $50.4 million, or 4.4%, to $1,186.1 million from $1,135.7 million for the six months ended March 30, 2019. Organic net sales increased $2.5 million, or 0.2%, as compared to the prior year six month period. Our branded product sales increased $22.5 million, and sales of other manufacturers’ products increased $27.9 million.

Pet net sales increased $36.2 million, or 5.3%, to $714.8 million for the six months ended March 28, 2020 from $678.6 for the six months ended March 30, 2019. The increase in net sales was due to both organic growth and sales from C&S Products, which we acquired in May 2019. Organic net sales increased $17.1 million, or 2.5%, due primarily to increased sales of dog treats, aided by consumable pantry loading associated with COVID-19, and increased third-party sales. These increases were partially offset by lower pet bed sales, negatively impacted by the November 2019 fire in one of our pet bedding facilities, and lower sales of live fish, due to a major retailer's decision in 2019 to exit the live fish business and the negative retail impact of reduced or eliminated foot traffic associated with COVID-19. Pet branded sales increased $21.9 million, and sales of other manufacturer's products increased $14.3 million.

Garden net sales increased $14.2 million, or 3.1%, to $471.3 million for the six months ended March 28, 2020 from $457.1 million for the six months ended March 30, 2019. The increase in net sales was due primarily to sales from Arden, which became 100% owned due to our acquisition of the remaining equity interest in February 2019. Organic sales declined $14.6 million, or 3.2%, due primarily to lower grass seed sales, negatively impacted by competitive pressures and reduced promotions in response to lower in store traffic due to COVID-19, and our exit of the fashion decor pottery product line in mid-2019. These decreases were partially offset by increased sales of third-party products due to new listings and expanded distribution. Garden branded sales increased $0.6 million, and sales of other manufacturers’ products increased $13.6 million.

Gross Profit

Gross profit for the six months ended March 28, 2020 increased $2.2 million, or 0.6%, to $338.4 million from $336.2 million for the six months ended March 30, 2019. Gross margin decreased 110 basis points to 28.5% for the six months ended March 28, 2020 from 29.6% for the six months ended March 30, 2019. The Pet segment was the driver of the gross profit increase, while both operating segments contributed to the decline in gross margin.

In the Pet segment, gross profit increased due primarily to the acquisition of C&S Products and increased sales in dog treats and chews, partially offset by the impact of the lower sales volume in our live fish business. The decline in gross margin was due primarily to the impact of the lower sales volume in our live fish business, an unfavorable product mix in sales of dog treats and chews and increased sales of third-party products partially offset by the contribution from our acquisition of C&S Products.

In the Garden segment, both gross profit and gross margin were negatively impacted by reduced grass seed sales and our exit from of the fashion décor pottery product line, which was partially offset by the positive impact of the Arden acquisition. Additionally, gross margin was negatively impacted by increased third-party sales.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $6.3 million, or 2.4%, to $270.2 million for the six months ended March 28, 2020 from $263.9 million for the six months ended March 30, 2019 due primarily to increased corporate expense. As a percentage of net sales, selling, general and administrative expenses decreased to 22.8% for the six months ended March 28, 2020, from 23.2% for the comparable prior year six month period; both operating segments contributed to the improvement.

Selling and delivery expense increased $1.8 million, or 1.4%, to $134.4 million for the six months ended March 28, 2020 from $132.6 million for the six months ended March 30, 2019. The increase was due primarily to recent acquisitions partially offset by cost saving initiatives enacted in response to a retailer's exit from the live fish business and our exit from the fashion decor pottery product line in 2019.

Warehouse and administrative expense increased $4.5 million, or 3.4%, to $135.8 million for the six months ended March 28, 2020 from $131.3 million for the six months ended March 30, 2019. Increased expense from our two recent acquisitions and in corporate expense was partially offset by cost reduction initiatives enacted in response to a retailer’s exit from the live fish business and our exit from the fashion décor pottery product line in 2019. Corporate expense increased due primarily to increased third-party expenses, which included costs related to the development of our Vision 2025 plan and increased legal expense, increased medical insurance and equity compensation expense. Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resource, and information technology functions.

Operating Income

Operating income decreased $4.1 million to $68.2 million for the six months ended March 28, 2020 from $72.3 million for the six months ended March 30, 2019. Our operating margin decreased to 5.7% for the six months ended March 28, 2020 from 6.4% for the six months ended March 30, 2019. Increased sales of $50.4 million and a 40 basis point improvement in selling, general and administrative expense as a percentage of net sales were more than offset by a 110 basis point decline in gross margin.

Pet operating income increased $7.1 million, or 12.5%, to $63.8 million for the six months ended March 28, 2020 from $56.7 million for the six months ended March 30, 2019. Adjusting for the $2.5 million intangible asset impairment in fiscal 2019, operating income increased $4.6 million. The increase in operating income was due to increased net sales of $36.2 million partially offset by a decline in gross margin and an increase in selling, general and administrative expense.

Garden operating income declined $4.0 million, or 8.3%, to $44.7 million for the six months ended March 28, 2020 from $48.7 million in the six months ended March 30, 2019. Adjusting for the non-cash gain from the fair value remeasurement of our previously held investment interest upon our acquisition of the remaining 55% interest of Arden in the prior six month period, garden operating income decreased $0.8 million. The decrease in operating income was due primarily to a lower gross margin partially offset by increased sales from the Arden acquisition.

Corporate operating expense increased $7.2 million to $40.3 million in the current six-month period from $33.1 million in the comparable fiscal 2019 period due primarily to increased third-party expenses, increased medical insurance and equity compensation expense.

Net Interest Expense

Net interest expense for the six months ended March 28, 2020 increased $1.5 million, or 9.2%, to $18.0 million from $16.5 million for the six months ended March 30, 2019. The increase in net interest expense was due to lower interest income from earnings on cash due to the lower rates available on our cash balance during the current year six-month period.

Debt outstanding on March 28, 2020 was $693.7 million compared to $697.8 million as of March 30, 2019. Our average borrowing rate for the current and prior year six-month periods was 5.8%.

Other Income

Other income (expense) was an expense of $0.7 million for the six-month period ended March 28, 2020 compared to income of $0.3 million for the six-month period ended March 30, 2019. The $1.0 million decrease was due primarily to the absence of income from our formerly held equity interest in Arden. The Arden business has been part of our consolidated results since our purchase of the remaining ownership interest in February 2019.

Income Taxes

Our effective income tax rate was 22.1% for the six month period ended March 28, 2020 compared to 21.0% for the six-month period ended March 30, 2019. The higher effective income tax rate in the current six-month period was due primarily to a lower stock compensation benefit compared to the prior year six-month period.

Net Income and Earnings Per Share

Our net income for the six months ended March 28, 2020 was $38.3 million, or $0.69 per diluted share, compared to $44.2 million, or $0.76 per diluted share, for the six months ended March 30, 2019.

Use of Non-GAAP Financial Measures

We report our financial results in accordance with accounting principles generally accepted in the United States (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including EBITDA and organic sales. Management believes these non-GAAP financial measures that exclude the impact of specific items (described below) may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods.

EBITDA is defined by us as income before income tax, net other expense, net interest expense and depreciation and amortization (or operating income plus depreciation and amortization expense). We present EBITDA because we believe that EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. EBITDA is used by our management to perform such evaluation. EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP. We believe that EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present EBITDA when reporting their results. Other companies may calculate EBITDA differently and it may not be comparable.

We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions.

The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. We believe that the non-GAAP financial measures provide useful information to investors and other users of our financial statements by allowing for greater transparency in the review of our financial and operating performance. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating our performance, and we believe these measures similarly may be useful to investors in evaluating our financial and operating performance and the trends in our business from management's point of view. While our management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.

Non-GAAP financial measures reflect adjustments based on the following items:

  • Gains from the fair value remeasurement of previously held investment interests: we have excluded the impact of the fair value remeasurement of a previously held investment interest as it represents an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of these gains supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.
  • Asset impairment charges: we have excluded the impact of asset impairments on intangible assets as such non-cash amounts are inconsistent in amount and frequency. We believe that the adjustment of these charges supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.

From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.

The non-GAAP adjustments reflect the following:

(1) During the second quarter of fiscal 2019, we recorded a preliminary, pending the finalization of the related purchase accounting, non-cash $3.2 million gain in our Garden segment from the fair value remeasurement of our previously held 45% interest in Arden upon our acquisition of the remaining 55% interest. The gain was recorded as part of selling, general and administrative costs in the condensed consolidated statements of operations.

(2) During the second quarter of fiscal 2019, we recognized a non-cash impairment charge in our Pet segment of $2.5 million related to the impairment of intangible assets caused by a retail customer exiting the live fish business. The adjustment was recorded as part of selling, general and administrative costs.

Operating Income Reconciliation GAAP to Non-GAAP Reconciliation (in thousands) For the Three Months Ended Consolidated March 28, 2020 March 30, 2019 GAAP to Non-GAAP Reconciliation (in thousands) For the Six Months Ended Consolidated March 28, 2020 March 30, 2019
GAAP operating income $66,105 $62,153 $68,170 $72,334
Previously held investment interest fair value remeasurement (1) — (3,215) — (3,215)
Intangible asset impairment (2) — 2,540 — 2,540
Non-GAAP operating income $66,105 $61,478 $68,170 $71,659
Pet Segment Operating Income Reconciliation GAAP to Non-GAAP Reconciliation (in thousands) For the Three Months Ended Pet March 28, 2020 March 30, 2019 GAAP to Non-GAAP Reconciliation (in thousands) For the Six Months Ended Pet March 28, 2020 March 30, 2019
GAAP operating income $33,617 $26,984 $63,839 $56,739
Intangible asset impairment (2) — 2,540 — 2,540
Non-GAAP operating income $33,617 $29,524 $63,839 $59,279
Garden Segment Operating Income Reconciliation GAAP to Non-GAAP Reconciliation (in thousands) For the Three Months Ended Garden March 28, 2020 March 30, 2019 GAAP to Non-GAAP Reconciliation (in thousands) For the Six Months Ended Garden March 28, 2020 March 30, 2019
GAAP operating income $53,020 $53,355 $44,652 $48,718
Previously held investment interest fair value remeasurement (1) — (3,215) — (3,215)
Non-GAAP operating income $53,020 $50,140 $44,652 $45,503

42

Organic Net Sales Reconciliation

We have provided organic net sales, a non-GAAP measure that excludes the impact of recent acquisitions and dispositions, because we believe it permits investors to better understand the performance of our historical business. We define organic net sales as net sales from our historical business derived by excluding the net sales from businesses acquired or exited in the preceding 12 months. After an acquired business has been part of our consolidated results for 12 months, the change in net sales thereafter is considered part of the increase or decrease in organic net sales.

GAAP to Non-GAAP Reconciliation (in millions) For the Three Months Ended March 28, 2020 Consolidated Percent change Pet Segment Percent change Garden Segment Percent change
Reported net sales - Q2 FY20 (GAAP) $703.2 $360.8 $342.4
Reported net sales - Q2 FY19 (GAAP) 673.7 338.2 335.5
Increase in net sales 29.5 4.4% 22.6 6.7% 6.9 2.1%
Effect of acquisition and divestitures on increase in net sales 26.1 9.9 16.2
Increase in organic net sales - Q2 FY20 $3.4 0.5% $12.7 3.8% $(9.3) (2.8)%
GAAP to Non-GAAP Reconciliation (in millions) For the Six Months Ended March 28, 2020 Consolidated Percent change Pet Segment Percent change Garden Segment Percent change
Reported net sales - Q2 FY20 YTD (GAAP) $1,186.1 $714.8 $471.3
Reported net sales - Q2 FY19 YTD (GAAP) 1,135.7 678.6 457.1
Increase in net sales 50.4 4.4% 36.2 5.3% 14.2 3.1%
Effect of acquisition and divestitures on increase in net sales 47.9 19.1 28.8
Increase (decrease) in organic net sales - Q2 FY20 YTD $2.5 0.2% $17.1 2.5% $(14.6) (3.2)%
EBITDA Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Three Months Ended March 28, 2020 Garden Pet Corp Total
Net income attributable to Central Garden & Pet — — — $42,704
Interest expense, net — — — 9,336
Other income — — — 979
Income tax expense — — — 12,648
Net income attributable to noncontrolling interest — — — 438
Sum of items below operating income — — — 23,401
Income (loss) from operations $53,020 $33,617 $(20,532) $66,105
Depreciation & amortization 3,324 8,441 1,411 13,176
EBITDA $56,344 $42,058 $(19,121) $79,281

43

EBITDA Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Three Months Ended March 30, 2019 Garden Pet Corp Total
Net income attributable to Central Garden & Pet — — — $42,391
Interest expense, net — — — 8,385
Other expense — — — (500)
Income tax expense — — — 11,546
Net income attributable to noncontrolling interest — — — 331
Sum of items below operating income — — — 19,762
Income (loss) from operations $53,355 $26,984 $(18,186) $62,153
Depreciation & amortization 2,312 8,039 1,526 11,877
EBITDA $55,667 $35,023 $(16,660) $74,030
EBITDA Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Six Months Ended March 28, 2020 Garden Pet Corp Total
Net income attributable to Central Garden & Pet — — — $38,287
Interest expense, net — — — 17,973
Other income — — — 674
Income tax expense — — — 10,920
Net income attributable to noncontrolling interest — — — 316
Sum of items below operating income — — — 29,883
Income (loss) from operations $44,652 $63,839 $(40,321) $68,170
Depreciation & amortization 6,619 16,931 2,766 26,316
EBITDA $51,271 $80,770 $(37,555) $94,486
EBITDA Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Six Months Ended March 30, 2019 Garden Pet Corp Total
Net income attributable to Central Garden & Pet — — — $44,194
Interest expense, net — — — 16,462
Other expense — — — (308)
Income tax expense — — — 11,819
Net income attributable to noncontrolling interest — — — 167
Sum of items below operating income — — — 28,140
Income (loss) from operations $48,718 $56,739 $(33,123) $72,334
Depreciation & amortization 5,138 16,095 2,996 24,229
EBITDA $53,856 $72,834 $(30,127) $96,563

Inflation

Our revenues and margins are dependent on various economic factors, including rates of inflation, energy costs, consumer attitudes toward discretionary spending, currency fluctuations, and other macro-economic factors which may impact levels of consumer spending. In certain fiscal periods, we have been adversely impacted by rising input costs related to domestic inflation, particularly relating to grain and seed prices, fuel prices and the ingredients used in our garden controls and fertilizer. Rising costs in those periods have made it difficult for us to increase prices to our retail customers at a pace sufficient to enable us to maintain margins.

Weather and Seasonality

Our sales of lawn and garden products are influenced by weather and climate conditions in the different markets we serve. Our Garden segment’s business is highly seasonal. In fiscal 2019, approximately 69% of our Garden segment’s net sales and 58% of our total net sales occurred during our second and third fiscal quarters. Substantially all of the Garden segment’s operating income is typically generated in this period, which has historically offset the operating loss incurred during the first fiscal quarter of the year.

Liquidity and Capital Resources

We have financed our growth through a combination of internally generated funds, bank borrowings, supplier credit, and sales of equity and debt securities to the public.

Our business is seasonal and our working capital requirements and capital resources track closely to this seasonal pattern. Generally, during the first fiscal quarter, accounts receivable reach their lowest level while inventory, accounts payable and short-term borrowings begin to increase. During the second fiscal quarter, receivables, accounts payable and short-term borrowings increase, reflecting the build-up of inventory and related payables in anticipation of the peak lawn and garden selling season. During the third fiscal quarter, inventory levels remain relatively constant while accounts receivable peak and short-term borrowings start to decline as cash collections are received during the peak selling season. During the fourth fiscal quarter, inventory levels are at their lowest, and accounts receivable and payables are substantially reduced through conversion of receivables to cash.

We service two broad markets: pet supplies and lawn and garden supplies. Our pet supplies businesses involve products that have a year round selling cycle with a slight degree of seasonality. As a result, it is not necessary to maintain large quantities of inventory to meet peak demands. Our lawn and garden businesses are highly seasonal with approximately 69% of our Garden segment’s net sales occurring during the second and third fiscal quarters. This seasonality requires the shipment of large quantities of product well ahead of the peak consumer buying periods. To encourage retailers and distributors to stock large quantities of inventory, industry practice has been for manufacturers to give extended credit terms and/or promotional discounts.

Operating Activities

Net cash used by operating activities increased by $13.4 million, from $79.3 million for the six months ended March 30, 2019, to $92.7 million of cash used for the six months ended March 28, 2020. The increase in cash used was due primarily to changes in our working capital accounts for the period ended March 28, 2020, as compared to the prior year period.

Investing Activities

Net cash used in investing activities decreased $3.2 million, from $27.6 million for the six months ended March 30, 2019 to $24.4 million during the six months ended March 28, 2020. The decrease in cash used in investing activities was due primarily to decreased acquisition activity, partially offset by increased capital expenditures in the current year compared to the prior year. During the second quarter of fiscal 2019, we acquired the remaining 55% interest in Arden Companies for approximately $11.0 million.

Financing Activities

Net cash used by financing activities increased $8.9 million, from $40.3 million for the six months ended March 30, 2019, to $49.2 million for the six months ended March 28, 2020. The increase in cash used by financing activities during the current year was due primarily to purchases of our common stock. During the six months ended March 28, 2020, we repurchased approximately 0.2 million shares of our voting common stock (CENT) on the open market at an aggregate cost of approximately $5.8 million, or approximately $26.53 per share, and 1.6 million shares of our non-voting Class A common stock (CENTA) on the open market at an aggregate cost of approximately $41.4 million, or approximately $25.89 per share. Additionally, during the six months ended March 30, 2019, we repaid approximately $36 million of acquired long-term debt subsequent to our acquisition of Arden Companies.

We expect that our principal sources of funds will be cash generated from our operations and, if necessary, borrowings under our $400 million asset backed revolving credit facility. Based on our anticipated cash needs, availability under our asset backed revolving credit facility and the scheduled maturity of our debt, we believe that our sources of liquidity should be adequate to meet our working capital, capital spending and other cash needs for at least the next 12 months. However, we cannot assure you that these sources will continue to provide us with sufficient liquidity and, should we require it, that we will be able to obtain financing on terms satisfactory to us, or at all.

We believe that cash flows from operating activities, funds available under our asset backed loan facility, and arrangements with suppliers will be adequate to fund our presently anticipated working capital and capital expenditure requirements for the foreseeable future. We previously estimated our capital expenditures, which are related primarily to replacements and expansion of and upgrades to plant and equipment and also investment in our continued implementation of a scalable enterprise-wide information technology platform, would be $45 million to $50 million in fiscal 2020. As a result of the uncertainties associated with the COVID-19 pandemic, we are reevaluating the appropriate amount of our fiscal 2020 capital expenditures.

As part of our growth strategy, we have acquired a number of companies in the past, and we anticipate that we will continue to evaluate potential acquisition candidates in the future. If one or more potential acquisition opportunities, including those that would be material, become available in the near future, we may require additional external capital. In addition, such acquisitions would subject us to the general risks associated with acquiring companies, particularly if the acquisitions are relatively large.

Total Debt

At March 28, 2020, our total debt outstanding was $693.7 million, as compared with $697.8 million at March 30, 2019.

Senior Notes

$300 Million 5.125% Senior Notes

On December 14, 2017, we issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). We expect to use the net proceeds from the offering to finance future acquisitions and for general corporate purposes.

We incurred approximately $4.8 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.

The 2028 Notes require semiannual interest payments on February 1 and August 1, commencing August 1, 2018. The 2028 Notes are unconditionally guaranteed on a senior basis by our existing and future domestic restricted subsidiaries who are borrowers under or guarantors of our senior secured revolving credit facility or who guarantee the 2023 Notes.

We may redeem some or all of the 2028 Notes at any time, at our option, prior to January 1, 2023 at the principal amount plus a “make whole” premium. At any time prior to January 1, 2021, we may also redeem, at our option, up to 35% of the original aggregate principal amount of the notes with the proceeds of certain equity offerings at a redemption price of 105.125% of the principal amount of the notes. We may redeem some or all of the 2028 Notes, at our option, at any time on or after January 1, 2023 for 102.563%, on or after January 1, 2024 for 101.708%, on or after January 1, 2025 for 100.854% and on or after January 1, 2026 for 100.0%, plus accrued and unpaid interest.

The holders of the 2028 Notes have the right to require us to repurchase all or a portion of the 2028 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2028 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all financial covenants as of March 28, 2020.

$400 Million 6.125% Senior Notes

In November 2015, we issued $400 million aggregate principal amount of 6.125% senior notes due November 2023 (the "2023 Notes"). In December 2015, we used the net proceeds from the offering, together with available cash, to redeem our $400 million aggregate principal amount of 8.25% senior subordinated notes due March 1, 2018 (the "2018 Notes") at a price of 102.063% of the principal amount and to pay fees and expenses related to the offering.

We incurred approximately $6.3 million of debt issuance costs in conjunction with these transactions, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.

The 2023 Notes require semiannual interest payments on May 15 and November 15. The 2023 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our senior secured revolving credit facility. The 2023 Notes are unsecured senior obligations and are subordinated to all of our existing and future secured debt, including our Credit Facility, to the extent of the value of the collateral securing such indebtedness.

We may redeem some or all of the 2023 Notes at any time, at our option, on or after November 15, 2018 for 104.594%, on or after November 15, 2019 for 103.063%, on or after November 15, 2020 for 101.531% and on or after November 15, 2021 for 100%, plus accrued and unpaid interest.

The holders of the 2023 Notes have the right to require us to repurchase all or a portion of the 2023 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2023 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all financial covenants as of March 28, 2020.

Asset-Based Loan Facility Amendment

On September 27, 2019, we entered into a Second Amended and Restated Credit Agreement (“Amended Credit Agreement”). The Amended Credit Agreement amended and restated the previous credit agreement dated April 22, 2016 and continues to provide up to a $400.0 million principal amount senior secured asset-based revolving credit facility, with up to an additional $200 million principal amount available with the consent of the Lenders, as defined, if we exercise the accordion feature set forth therein (collectively, the “Amended Credit Facility”). The Amended Credit Facility now matures on September 27, 2024. We may borrow, repay and reborrow amounts under the Amended Credit Facility until its maturity date, at which time all amounts outstanding under the Credit Facility must be repaid in full.

The Amended Credit Facility is subject to a borrowing base, reduced capacity due to reserves and certain other restrictions. The borrowing base is calculated using a formula initially based upon eligible receivables and inventory minus certain reserves, and was $400 million as of March 28, 2020. The Amended Credit Facility also allows us to add real property to the borrowing base so long as the real property is subject to a first priority lien in favor of the Administrative Agent for the benefit of the Lenders. Proceeds of the Amended Credit Facility will be used for general corporate purposes. The Amended Credit Facility includes a $50 million sublimit for the issuance of standby letters of credit and an increased $40 million sublimit for short-notice borrowings. We incurred approximately $1.6 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal expenses. The debt issuance costs are being amortized over the term of the Amended Credit Facility. As of March 28, 2020, there were no borrowings outstanding and no letters of credit outstanding under the Credit Facility. There were other letters of credit of $3.2 million outstanding as of March 28, 2020. Subsequent to our quarter ended March 28, 2020, we borrowed $200 million under our revolving credit facility to increase financial flexibility while we navigate an uncertain COVID-19 economic environment.

Borrowings under the Amended Credit Facility bear interest at an index based on LIBOR or, at our option, the Base Rate (defined as the highest of (a) the SunTrust prime rate, (b) the Federal Funds Rate plus 0.50%, (c) one-month LIBOR plus 1.00%), plus, in either case, an applicable margin based on our consolidated senior leverage ratio and (d) 0.00%. Such applicable margin for LIBOR-based borrowings fluctuates between 1.00%-1.50% (previously between 1.25% and 1.50%) and was 1.00% as of March 28, 2020, and such applicable margin for Base Rate borrowings fluctuates between 0.00%-0.50% (previously 0.25%-0.50%), and was 0.00% as of March 28, 2020. An unused line fee shall be payable monthly in respect of the total amount of the unutilized Lenders’ commitments and short-notice borrowings under the Amended Credit Facility. Letter of credit fees at the applicable margin on the average undrawn and unreimbursed amount of letters of credit shall be payable monthly and a facing fee of 0.125% shall be paid on demand for the stated amount of each letter of credit. We are also required to pay certain fees to the administrative agent under the Amended Credit Facility. As of March 28, 2020, the applicable interest rate related to Base Rate borrowings was 3.3%, and the applicable interest rate related to LIBOR-based borrowings was 2.0%. Banks currently reporting information used to set LIBOR will stop doing so after 2021. Various parties, including government agencies, are seeking to identify an alternative rate to replace LIBOR. We are monitoring their efforts, and we will likely amend contracts to accommodate any replacement rate where it is not already provided.

The administering regulatory authority announced it intends to phase out London Interbank Offered Rate (LIBOR) by the end of 2021. We have both LIBOR-denominated and Euro Interbank Offer Rate (EURIBOR)-denominated indebtedness. Once LIBOR is phased out it will be replaced by an alternative method equivalent to LIBOR. Any legal or regulatory changes made in response to LIBOR’s future discontinuance may result in, among other things, a sudden or prolonged increase or decrease in LIBOR, a delay in the publication of LIBOR, or changes in the rules or methodologies in LIBOR. In addition, alternative methods to LIBOR may be impossible or impracticable to determine. The transition to alternatives to LIBOR could be modestly disruptive to the credit markets, and while we do not expect that the transition from LIBOR and risks related thereto will have a material adverse effect on our financing costs, it is still uncertain at this time.

The Amended Credit Facility continues to contain customary covenants, including financial covenants which require us to maintain a minimum fixed charge coverage ratio of 1.00:1.00 upon triggered quarterly testing (e.g. when availability falls below certain thresholds established in the agreement), reporting requirements and events of default. The Amended Credit Facility is secured by substantially all assets of the borrowing parties, including (i) pledges of 100% of the stock or other equity interest of each domestic subsidiary that is directly owned by such entity and (ii) 65% of the stock or other equity interest of each foreign subsidiary that is directly owned by such entity. We were in compliance with all financial covenants under the Credit Facility during the period ended March 28, 2020.

Off-Balance Sheet Arrangements

There have been no material changes to the information provided in our Annual Report on Form 10-K for the fiscal year ended September 28, 2019 regarding off-balance sheet arrangements.

Contractual Obligations

There have been no material changes outside the ordinary course of business in our contractual obligations set forth in the Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources in our Annual Report on Form 10-K for the fiscal year ended September 28, 2019, except as set forth below.

In December 2019, performance-based criteria associated with the $6 million contingent consideration liability related to our fiscal 2017 acquisition of Segrest, Inc. were met and accordingly, the entire amount was released out of an independent escrow account to the former owners as of December 28, 2019.

Subsequent to quarter end, the Company borrowed $200 million under its revolving credit facility to increase financial flexibility while it navigates an uncertain COVID-19 economic environment.

New Accounting Pronouncements

Refer to Footnote 1 in the notes to the condensed consolidated financial statements for new accounting pronouncements.

Critical Accounting Policies, Estimates and Judgments

There have been no material changes to our critical accounting policies, estimates and assumptions or the judgments affecting the application of those accounting policies since our Annual Report on Form 10-K for the fiscal year ended September 28, 2019.

Market risk

As filed, 164 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There has been no material change in our exposure to market risk from that discussed in our Annual Report on Form 10-K for the fiscal year ended September 28, 2019.

Controls and procedures

As filed, 1,559 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures. Our Chief Executive Officer and principal financial officer have reviewed, as of the end of the period covered by this report, the “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) that ensure that information relating to the Company required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported in a timely and proper manner and that such information is accumulated and communicated to our management, including our Chief Executive Officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based upon this review, such officers concluded that our disclosure controls and procedures were effective as of March 28, 2020.

(b) Changes in Internal Control Over Financial Reporting. Our management, with the participation of our Chief Executive Officer and our principal financial officer have evaluated whether any change in our internal control over financial reporting occurred during the second quarter of fiscal 2020. We implemented controls and a new lease accounting system related to the adoption of ASC 842 and the related financial statement reporting. There were no other changes in our internal control over financial reporting during the second quarter of fiscal 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 4,747 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Except as set forth below, there have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year ended September 28, 2019.

The COVID-19 pandemic has impacted how we are operating our business, and the duration and extent to which this will impact our future results of operations and overall financial performance remains uncertain.

The outbreak of the COVID-19 virus in Wuhan, China in late 2019 and subsequent spread of the virus throughout the world has impacted our day-to-day operations and the operations of the vast majority of our customers, suppliers, and consumers. The World Health Organization’s March 2020 declaration of the COVID-19 outbreak as a global pandemic has resulted in authorities implementing numerous measures to contain the virus, including travel bans and restrictions, border closures, quarantines, shelter-in-place orders, and business limitations and shutdowns. COVID-19 has adversely affected and may continue to adversely affect how we and our customers are operating our businesses and overall demand for our products.

We have experienced varying impacts to our Garden and Pet businesses due to COVID-19. In March, we experienced increased demand in pet consumables due to consumers stocking up on products as the COVID-19 shelter-in-place mandates were implemented. We also saw reduced consumption on other items, such as live fish and live plants, due to in-store curtailments of foot traffic and limited access to outdoor garden departments. In addition, we saw a pronounced shift to the e-commerce channel and a slow-down in brick and mortar retailers.

Although our facilities have largely been exempt or partially exempt from government closure orders as essential businesses, to support the health and well-being of our employees, customers and communities, we are requiring a significant portion of our workforce to work remotely, and local and state governments in the United States and in the United Kingdom have imposed shelter-in-place requirements and certain travel restrictions, all of which have changed how we operate our business. For our employees who are not working remotely, we have taken several actions to ensure their safety, including instituting workplace safety measures and ensuring the availability of personal protective equipment. While we believe that such actions will help to ensure the safety of our employees, there is no guarantee that such actions will ultimately be successful.

We have experienced temporary closures of certain production facilities and distribution centers, though there has not been a material impact from a plant closure to date. At some of our facilities, we have experienced reduced productivity and increased employee absences, which we expect to continue during the current pandemic. The pandemic and near-term increase in demand for pet consumables has created operational challenges for our distribution network, though none have had a material impact on our results to date. In our supply chain, it is possible we will experience increased operational and logistics costs. We may experience additional disruptions in our supply chain as the pandemic continues, though we cannot reasonably estimate the potential impact or timing of those events, and we may not be able to mitigate such impact.

We anticipate many small customers may permanently close, and we may experience collection delinquencies as customers seek to preserve liquidity. Additionally, we have small company equity method investees, intangible assets and other long-lived assets whose value is dependent on cashflows. These investments and other assets could be impacted by the COVID-19 pandemic and, therefore, may be more susceptible to impairment. Our assessment of possible asset impairment involves numerous assumptions that involve significant judgment. As a result of the uncertainties associated with the COVID-19 pandemic, the shelter-in-place orders and the post COVID-19 economic recovery, these factors will be even more difficult to estimate. Although no impairment charges were recorded in our second fiscal quarter, we may be required to write-off certain assets that could be material in future periods.

The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the severity and transmission rate of the virus, the extent and effectiveness of containment actions and the impact of these and other factors on our employees, independent contractors and customers and consumers. If we are not able to respond to and manage the impact of such events effectively, our business will be harmed.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-03-28. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-12-29 to 2020-03-28$703.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2019-09-29 to 2020-03-28$1.19bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-12-29 to 2020-03-28$496.1mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2019-09-29 to 2020-03-28$847.7mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-12-29 to 2020-03-28$207.1mus-gaap:GrossProfit
Gross profit6 months2019-09-29 to 2020-03-28$338.4mus-gaap:GrossProfit
Selling, general and administrative3 months2019-12-29 to 2020-03-28$141.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2019-09-29 to 2020-03-28$270.2mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-12-29 to 2020-03-28$66.1mus-gaap:OperatingIncomeLoss
Operating income6 months2019-09-29 to 2020-03-28$68.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-12-29 to 2020-03-28$10.8mus-gaap:InterestExpense
Interest expense6 months2019-09-29 to 2020-03-28$21.4mus-gaap:InterestExpense
Income tax3 months2019-12-29 to 2020-03-28$12.6mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-09-29 to 2020-03-28$10.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-12-29 to 2020-03-28$42.7mus-gaap:NetIncomeLoss
Net income6 months2019-09-29 to 2020-03-28$38.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-12-29 to 2020-03-28$0.78us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2019-09-29 to 2020-03-28$0.69us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-12-29 to 2020-03-28$0.79us-gaap:EarningsPerShareBasic
Basic EPS6 months2019-09-29 to 2020-03-28$0.70us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-12-29 to 2020-03-2854,952,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2019-09-29 to 2020-03-2855,220,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2019-09-29 to 2020-03-28−$92.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-09-29 to 2020-03-28$19.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2019-09-29 to 2020-03-28$48.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-03-28$331.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-03-28$1.36bnus-gaap:AssetsCurrent
Total assetsAt period end2020-03-28$2.17bnus-gaap:Assets
Current liabilitiesAt period end2020-03-28$357.1mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2020-03-28$693.6mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-03-28$103.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2020-03-28$993.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000887733-20-000007. Last ingested by Listed: Nov 10, 2026, 04:49 ET. Listed shows no prices and gives no investment advice.